We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
Cap. Flow
-$3.6B
Cap. Flow %
-4.89%
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$269M
2
MSFT icon
Microsoft
MSFT
+$172M
3
AMZN icon
Amazon
AMZN
+$114M
4
DIS icon
Walt Disney
DIS
+$62.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.8M

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Financials 14.26%
3 Healthcare 12.86%
4 Consumer Discretionary 12.27%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAVM icon
2901
PAVmed
PAVM
$33.9M
$137K ﹤0.01%
68
+11
+19% +$16.5K
BMTX
2902
DELISTED
BM Technologies, Inc.
BMTX
$137K ﹤0.01%
+11,798
New +$160K
EARN
2903
Ellington Residential Mortgage REIT
EARN
$165M
$136K ﹤0.01%
11,082
-360
-3% -$4.46K
PAYS icon
2904
Paysign
PAYS
$705M
$135K ﹤0.01%
30,895
EVFM
2905
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$134K ﹤0.01%
5,123
+51
+1% +$2.32K
ASUR icon
2906
Asure Software
ASUR
$250M
$131K ﹤0.01%
17,087
+375
+2% +$3K
SMSI icon
2907
Smith Micro Software
SMSI
$16.2M
$131K ﹤0.01%
594
-60
-9% -$15.9K
PROS
2908
DELISTED
ProSight Global, Inc.
PROS
$131K ﹤0.01%
10,396
-380
-4% -$4.82K
GSIT icon
2909
GSI Technology
GSIT
$258M
$126K ﹤0.01%
18,892
OPTN
2910
DELISTED
OptiNose
OPTN
$126K ﹤0.01%
2,272
CHMA
2911
DELISTED
Chiasma, Inc. Common Stock
CHMA
$126K ﹤0.01%
40,104
-1,280
-3% -$4.91K
FENC icon
2912
Fennec Pharmaceuticals
FENC
$402M
$123K ﹤0.01%
19,802
-220
-1% -$1.66K
NERV icon
2913
Minerva Neurosciences
NERV
$199M
$122K ﹤0.01%
5,219
PR
2914
Permian Resources
PR
$16.9B
$120K ﹤0.01%
28,456
+1,211
+4% +$4.25K
NBSE
2915
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$120K ﹤0.01%
809
-21
-3% -$3.81K
LNSR icon
2916
LENSAR
LNSR
$74.2M
$118K ﹤0.01%
16,269
-202
-1% -$1.57K
LFVN icon
2917
LifeVantage
LFVN
$85.3M
$117K ﹤0.01%
12,555
-800
-6% -$7.46K
GDP
2918
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$117K ﹤0.01%
12,386
GNPX icon
2919
Genprex
GNPX
$2.16M
$116K ﹤0.01%
1
MBIO icon
2920
Mustang Bio
MBIO
$4.55M
$115K ﹤0.01%
46
+2
+5% +$5.95K
ADMA icon
2921
ADMA Biologics
ADMA
$2.22B
$114K ﹤0.01%
64,698
+100
+0.2% +$229
ORGS
2922
DELISTED
Orgenesis Inc. Common Stock
ORGS
$112K ﹤0.01%
1,946
+12
+0.6% +$782
BXG
2923
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$112K ﹤0.01%
10,400
TH icon
2924
Target Hospitality
TH
$1.64B
$111K ﹤0.01%
44,252
-100
-0.2% -$185
SNFCA icon
2925
Security National Financial
SNFCA
$251M
$110K ﹤0.01%
15,706
+838
+6% +$5.84K

Similar funds

RhumbLine Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.

  • RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
  • RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
  • RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
  • RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
  • RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
  • RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.